1 / 8

Antibodies Market To Surpass US$ 384.0 Billion By 2027 - Coherent Market Insights

Antibodies Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

SANJAYCMI
Download Presentation

Antibodies Market To Surpass US$ 384.0 Billion By 2027 - Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ANTIBODIES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Antibodies Market - Overview An antibody (Ab), also known as an immunoglobulin (Ig), is secreted by B cells of the adaptive immune system, mostly by differentiated B cells called plasma cells. Antibodies are used in the treatment of various cancers and other diseases such as rheumatoid arthritis and psoriasis. Statistics: The global Antibodies Market is estimated to account for US$ 147,385.1 Mn in terms of value and is expected to reach US$ 384,011.6 Mn by the end of 2027. Global AntibodiesMarket: Drivers Increasing demand for antibody-drug conjugates (ADCs) is expected to propel growth of the global antibodies market over the forecast period. specifically bind tumour-associated target antigens and deliver a highly potent cytotoxic agent. This has led to increasing adoption of ADCs for the treatment of cancer. ADCs use monoclonal antibodies to Global AntibodiesMarket: Opportunities Major players in the market can focus on expanding their presence in Africa, especially with focus on launching generic products. This is owing to high incidence of cancer in the region and regulatory reforms for development and registration of biosimilars. For instance, according to the World Health Organization. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/antibodies-market-2629 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Key Takeaways: The monoclonal antibodies sub segment in the drug type segment in global antibodies market was valued at US$ 124,936.8 Mn in 2018 and is expected to reach US$ 367,264.6 Mn by 2027 at a CAGR of 12.6% during the forecast period. Increasing approval and robust pipeline of novel human monoclonal antibodies is expected to aid in the segment growth. In the years 2014-2018, highest number of monoclonal antibodies (i.e. 6) were approved in the U.S. in 2018 and Europe witnessed highest number of monoclonal antibodies (i.e. 8) approval in 2017. Out of 8 approvals in Europe in 2017, 4 were biosimilar versions of Humira (adalimumab). The cancer sub segment in disease indication segment held dominant position in the global antibodies market in 2018, accounting for 54.8% share in terms of value. High prevalence of cancer and frequent approval and launch of novel monoclonal antibodies in the market is expected to significantly drive growth of the cancer segment over the forecast period. The hospitals sub segment in end user segment held dominant position in the global antibodies market in 2018, accounting for 86.4% share in terms of value, followed by long term care facilities, and research institutes, respectively. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2629 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Regulations Europe In the European Union (EU), biological products including therapeutic monoclonal antibodies are subject to the approval from European Medicines Agency (EMA) through centralized procedure Manufacturers of all the biological products are required to get the marketing authorization application (MAA) prior to the marketing of any biological drugs in the European market Centralized MAA for biological products obtained under Regulation (EC) No 726/2004 of the European Parliament And Of The Council allows the applicant to market their product in all the 27 member countries For biological drugs which have got orphan drug designation should obtain MAA as per Regulation (EC) No 141/2000 of the European Parliament And Of The Council Global Antibodies Market: Competitive Landscape Major players operating in the global antibodies market include, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2629 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related